Navigation Links
Biocom CEO Joe Panetta Appointed to California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee by Governor Jerry Brown
Date:1/13/2014

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Biocom, the association for the Southern California life sciences community, announced that its president and CEO, Joe Panetta, has been appointed to the California Institute for Regenerative Medicine's (CIRM) Independent Citizens' Oversight Committee (ICOC) by Governor Jerry Brown.

(Logo:  http://photos.prnewswire.com/prnh/20130228/LA69104LOGO)

"This is an opportunity to work alongside patient advocates, researchers and leaders in the biotechnology space to guide the development of experimental medical treatments through regulatory bodies and ultimately to the patient," said Joe Panetta, who will continue serving as president and CEO for Biocom.

Responsibilities of the CIRM 29-member Governing Board include: (1) adopting scientific, medical, ethical, and intellectual property policies; (2) making final decisions on all grant and loan awards; and (3) overseeing the operations of CIRM.

About California Institute for Regenerative Medicine (CIRM)

CIRM was established in November 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was overwhelmingly approved by voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research.

About Biocom

Biocom is one of the largest regional life science associations in the world, representing more than 600 member companies in Southern California. The association focuses on initiatives that position the region's life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit the organization's Web site at http://www.biocom.org or call (858) 455-0300.

Biocom media contact:
Cammy Duong
cammy@canalecomm.com
(619) 849-5382

 


'/>"/>
SOURCE Biocom
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology
2. Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
3. Life Science Veterans Highlight Opportunities at BIOCOM 3rd Annual Global Partnering Conference
4. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
5. Biocom Announces 2013 DeviceFest & Expo Award Winners
6. Nelson Laboratories to Offer Free Biocompatibility Consultations During MEDevice Forum San Diego
7. Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery
8. Herb Baer Appointed President of Polar USA
9. New Executive Vice President Commercial Appointed
10. Israel Makov Appointed Chairman of Sun Pharma Board
11. Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):